Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to further evaluate the safety of Olopatadine Ophthalmic
Solution 0.1% in Japanese children with allergic conjunctivitis.